Teladoc Health, Inc. (TDOC) · Aug 31, 2026 · Exec change

Teladoc names Michael Grasher CFO, but severance terms—not operations—drive the filing

CFO appointment — 12-month severance; 18 months after change of control

Teladoc formalizes Michael Grasher’s CFO role with 12-month severance and enhanced change-of-control protection, but discloses no operating update.

The CFO change itself is now formalized, not an earnings surprise. The agreement confirms that Michael Grasher will serve as CFO, but the appointment was publicly announced on August 31, 2026, so the identity and role were already visible to investors by the filing date. 〔0〕

The contract gives Grasher meaningful downside protection if Teladoc terminates him without cause. Outside a change of control, he receives 12 months of base-salary continuation, COBRA coverage for up to 12 months, certain bonus payments, and accelerated service-based equity vesting scheduled within the following year. 〔1〕

Key termDisclosed provision
Severance outside change of control12 months of base salary (Section 2(a))
Health coverage outside change of controlUp to 12 months of COBRA premiums (Section 2(a)(v))
Severance after change of control18 months of base salary (Section 2(b))
Additional change-of-control payment100% of target bonus (Section 2(b))
Equity after change of controlImmediate time-based vesting; performance awards remain eligible (Section 2(b))
Restrictive covenants12-month non-solicitation and non-competition period (Section 4)

Change-of-control protection is materially richer, but its dollar cost cannot be assessed from this filing. If Grasher is terminated without cause or resigns for good reason within 12 months after a change of control, the salary continuation extends to 18 months, he receives an additional 100% of target bonus, and all unvested equity awards vest as to time. 〔2〕 〔3〕

Net read: neutral because this is a personnel and compensation disclosure, not a change to Teladoc’s business outlook. The terms are important for future transaction or retention economics, but the filing gives no salary, target-bonus, equity-grant, performance, guidance, or capital-allocation figures against which to claim a beat or miss. The appointment direction was partly known; the severance mechanics are the new detail.

What to watch next

Grasher’s first quarterly report

Original filing on SEC EDGAR

More Teladoc Health, Inc. news

Teladoc names Michael Grasher CFO, but severance terms—not operations—drive the filing | TDOC Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.